Methyl 2-(4-Formylphenyl)benzoate - CAS 144291-47-4
Catalog: |
BB059695 |
Product Name: |
Methyl 2-(4-Formylphenyl)benzoate |
CAS: |
144291-47-4 |
Synonyms: |
4-[2-(Methoxycarbonyl)phenyl]benzaldehyde; Methyl 4'-formylbiphenyl-2-carboxylate; 4'-Formyl-[1,1'-biphenyl]-2-carboxylic Acid Methyl Ester |
IUPAC Name: | methyl 2-(4-formylphenyl)benzoate |
Description: | Methyl 2-(4-Formylphenyl)benzoate is a useful synthetic compound. |
Molecular Weight: | 240.25 |
Molecular Formula: | C15H12O3 |
Canonical SMILES: | COC(=O)C1=CC=CC=C1C2=CC=C(C=C2)C=O |
InChI: | InChI=1S/C15H12O3/c1-18-15(17)14-5-3-2-4-13(14)12-8-6-11(10-16)7-9-12/h2-10H,1H3 |
InChI Key: | MNUSHZDUHWBMSZ-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3327001-A1 | Novel compound having blt inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient | 20150724 |
JP-2018528173-A | Novel compound having BLT inhibitory activity and composition for preventing or treating inflammatory diseases comprising the same as an active ingredient | 20150724 |
KR-101796390-B1 | Novel compound having BLT-inhibitory activity and composition for preventing or treating inflammatory diseases comprising the same as an active ingredient | 20150724 |
KR-20170012151-A | Novel compound having BLT-inhibitory activity and composition for preventing or treating inflammatory diseases comprising the same as an active ingredient | 20150724 |
US-10494333-B2 | Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient | 20150724 |
US-2018215706-A1 | Novel compound having blt inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient | 20150724 |
WO-2017018751-A1 | Novel compound having blt inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient | 20150724 |
JP-6814794-B2 | A novel compound having BLT inhibitory activity and a composition for preventing or treating inflammatory diseases containing the same as an active ingredient. | 20150724 |
CN-108349875-B | Compound having BLT inhibitory activity and composition for preventing or treating inflammatory disease comprising the same as active ingredient | 20150724 |
KR-101373705-B1 | Novel biphenyl derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical compositions for the prevention or treatment of inflammatory diseases or autoimmune diseases comprising the same as an active ingredient | 20110805 |
Complexity: | 292 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 240.078644241 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 240.078644241 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 43.4Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS